Highlights Infinity Pharmaceuticals, Inc.

Equities

INFI.Q

US45665G3039

End-of-day quote OTC Markets Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	-99.96%

Mar. 25	North American Morning Briefing : Tech in Focus on -2-	DJ
Mar. 25	Infinity Pharmaceuticals, Inc. Went Out of Business	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

North American Morning Briefing : Tech in Focus on -2-	Mar. 25	DJ
An unknown healthcare investment firm acquired Substantially all of the assets of Infinity Pharmaceuticals, Inc. (OTCPK:INFI.Q).	Feb. 14	CI
North American Morning Briefing : Tech Likely to -2-	Jan. 19	DJ
Infinity Pharmaceuticals Shares Fall Ahead of Expected Suspension From Nasdaq Trading on Sept. 14	23-09-13	MT
Infinity Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
MEI Pharma, Inc. cancelled the acquisition of Infinity Pharmaceuticals, Inc. from The Vanguard Group, Inc. and others.	23-07-22	CI
MEI Pharma Shareholders Anson Funds, Cable Car Capital Seek to Remove 'Entire' Board While Infiniti Deal Progresses	23-07-17	MT
Infinity Pharmaceuticals Shareholders Approve MEI Pharma Merger Deal	23-07-14	MT
MEI Pharma Pushes Back Special Shareholder Meeting to Decide on Pending Infinity Pharmaceuticals Merger	23-07-14	MT
MEI Pharma Urges Shareholders to Vote for Pending Infinity Pharmaceuticals Merger	23-07-11	MT
Infinity Pharmaceuticals, Inc. Provides Additional Information on MARIO-8 Study Evaluating Eganelisib in Combination with the PD-1 Targeted Checkpoint Inhibitor Pembrolizumab (KEYTRUDAÂ®) in Patients with Squamous Cell Cancer of the Head and Neck	23-07-10	CI
MEI Pharma Reiterates Support for Infinity Deal After Anson, Cable Car Criticism	23-06-27	MT
MEI Pharma Says Board Rejects $8 Per-Share Cash Acquisition Bid; Recommends Merger Deal With Infinity Pharmaceuticals	23-06-01	MT
Infinity Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-09	CI
INFINITY PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Infinity Pharmaceuticals, Inc. - INFI	23-02-27	BU
Infinity Pharmaceuticals : MEI Pharma and Infinity Pharmaceuticals Merger Announcement	23-02-24	PU
MEI Pharma, Infinity Pharmaceuticals to Merge in All-Stock Deal	23-02-23	MT
MEI Pharma, Inc. entered into a definitive merger agreement to acquire Infinity Pharmaceuticals, Inc. from The Vanguard Group, Inc. and others for $28.8 million.	23-02-22	CI
Earnings Flash (INFI) INFINITY PHARMACEUTICALS Reports Q3 Loss $-0.12 Per Share	22-11-14	MT
Infinity Pharmaceuticals, Inc. Provides Earnings Guidance for the Year 2022	22-11-14	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Infinity Pharmaceuticals, Inc.

Equities

INFI.Q

US45665G3039

Highlights

Filters